Dr Jack Allocca is a researcher in the fields of psychedelic pharmacology, machine learning and the neuroscience of altered states of consciousness. With his multidisciplinary background and diverse experiential frameworks, he rapidly and intuitively maps an individual’s blind spots delivering a precise understanding of where their greatest growth opportunities lie. Using these unique methods he supports entrepreneurs and high impact individuals with leveraging altered states across their professional and personal life – maximizing meaning, creativity and value creation. These deeply personal upgrades enable them to future-proof their businesses in order to withstand the competition brought on by emerging technologies.
Dr Allocca is also the Founder and CEO of Somnivore Pty Ltd, which provides disruptive machine learning solutions to neuroscience laboratories which vastly reduces their need for human resources and provides them with the capacity to push the boundaries on research around the nature of consciousness, from drug discovery, sleep medicine and psychedelic science. He is an advisor to multiple psychedelic pharmacology projects undertaken in laboratories using Somnivore technology across the US and Europe.
Dr Allocca’s explorations have since taken him to some of the most unusual and remote places in over 60 countries where he has investigated traditional and modern technologies to access altered states of consciousness, thriving in extreme natural environments, conflict zones, remote human settlements, and cutting edge neuroscience laboratories. He explores the fringes of the world, the body, and the mind, in order to enhance the service, meaning and impact of the human experience through entrepreneurship with a lens of radical self-expression, adventure and play.